ERBB2 and breast carcinoma: Therefore, accurate identification of HER2 amplification status in breast carcinomas is of important diagnostic and treatment value and is necessary to ensure adequate patient treatment management, better treatment planning, and avoid patient exposure to unnecessary and potentially harmful treatments.